Call for Abstract
11th World Congress on Cell & Tissue Science, will be organized around the theme “Advancement and Challenges Long-Held on Cell and Tissue Science”
Celltissuescience 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Celltissuescience 2018
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Tissue engineering is an attempt, technique, or technology made or at some point applied towards the preternatural generation, regeneration, or restoration of native tissue structure and function using biological components. Once categorized as a sub-field, due to the scope and importance it has been considered as a field in its own.The goal of tissue engineering is to functional constructs that restore, replace, or improve damaged or wounded tissues or organs. Artificial skin and cartilage are good examples for tissues engineering that have been approved by the FDA. For proper functioning of these tissues certain requirement is needed like mechanical and structural properties.Regenerative medicine is a broad field that includes tissue engineering but also incorporates research on self-healing where the body uses its own systems or with the help of foreign biological material to recreate cells and reconstruct into tissues and organs.
- Track 1-1Regenerative medicine
- Track 1-2Histopathology
- Track 1-3Tissue Biomarkers
- Track 1-4Tissue Remodelling
Tumour, a mass of abnormal tissue that arises without perceived cause from preexisting body cells that has no purposeful function and is characterized by a tendency to independent and restricted growth. Tumour is quite different from inflammatory and other swellings because the cells in tumors are quite abnormal in appearance and functional characteristics. Abnormal cells are the kind that generally makes up tumors. One or more alterations in the normal cells can lead to tumor cells like (1) Hypertrophy, an increase in the size of individual cells. (2) Hyperplasia, an increase in the number of cells within a given zone and in some instances it may constitute into tumor formation.(3)Anaplasia, a regression of the physical characteristics of a cell toward a more primitive undifferentiated type.
- Track 2-1Cancer Stem Cells And Drug Resistance
- Track 2-2Tumor Suppressor Genes
- Track 2-3Targeted Cancer Therapies
- Track 2-4Gene Expression Modulators
- Track 2-5Pathology
The wide array of biospecimens (including blood, saliva, plasma, and pure DNA) maintained in biobanks is delineating as libraries of the human organism. They’re rigorously characterized to see the final and distinctive options of the continual cell line and therefore the absence or presence of contaminants, thus establishing a basic understanding regarding the staple from that the biological product is being derived and maintained. Biobanks catalog specimen’s victimization genetic and alternative traits, like age, gender, blood type, and quality. Some samples are classified in line with environmental factors, like whether or not the donor had been exposed to radiation or another substance that may have an effect on human genes. Researchers access bio-banks once they are in need of specimen with similar traits for their research studies.
- Track 3-1Identification of Genetic Variation or SNPs
- Track 3-2Integrating Biobanks
- Track 3-3Data Systems and Records Management
- Track 3-4Sample Storage and Distribution Management System
Tissue substitutes are a heterogeneous group of wound coverage materials that aid in wound closure and replace the functions of the tissue, either temporarily or permanently, depending on the product characteristics. These substances are alternatives to the standard wound coverage in circumstances when standard therapies are not desirable.
- Track 4-1Skin Substitutes
- Track 4-2Reducing the Cost of Substitution
- Track 4-3Tissue Remodeling
- Track 4-4Bioartificial Constructs
Biomaterials are being employed for the health care applications from ancient times. However subsequent evolution has made them a lot of versatile and has multiplied their utility. Biomaterials have revolutionized the areas like bioengineering and tissue engineering for the development of novel methods to combat life-threatening diseases. Alongside biomaterials, stem cell technology is additionally getting used to enhance the present aid facilities.
- Track 5-1Polymer Synthesis
- Track 5-23D Printer
- Track 5-3Gene Vector Design
Tissue engineering of musculoskeletal tissues, notably bone and cartilage, may be a rapidly advancing field. In bone, technology has focused on bone graft substitute materials and also the development of biodegradable scaffolds. Recently, tissue engineering strategies have included cell and gene therapy. The availability of growth factors and the expanding knowledge base concerning the genetics and regulation of bone formation have generated new materials for tissue engineering applications. This information base also has benefited cartilage tissue engineering. The problems are more complex, however, and the solutions appear more elusive. Advances in scaffold design and cell culture have improved the prognosis for success.
- Track 6-1Principles of Bone and Cartilage Reconstruction
- Track 6-2Cartilage Repair
- Track 6-3Gene Therapy
- Track 6-4Scaffolds Designing
Cancer stem cells (CSCs) are cancer cells (found among tumors or hematological cancers) that possess characteristics related to traditional stem cells, specifically the flexibility to offer a rise to a variety of cells found during a specific cancer sample. CSCs are so tumorigenic (tumor-forming), perhaps in contrast to alternative non-tumorigenic cancer cells. CSCs might generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell varieties. Such cells are hypothesized to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.
- Track 7-1Biomarkers of Cancer Stem Cells
- Track 7-2Cancer Immunotherapy
- Track 7-3Targeted Cancer Therapies
Cell therapy is therapy during which cellular material is injected into a patient. Nowadays 2 distinct classes of cell therapy are: the first class is cell therapy in mainstream drugs. This is often the topic of intense research and also the basis of potential therapeutic benefit. The second class is in alternative medicine and perpetuates the practice of injecting animal materials in an effort to cure disease. The target of cell therapy is to revive the lost function instead of manufacture a brand new organ that may cause duplicity and undesirable effects. Gene therapy is that the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease. Gene therapy may be a way to fix a genetic drawback at its supply. The polymers are either translated into proteins, interfere with target gene expression, or presumably correct genetic mutations. The foremost common kind uses a deoxyribonucleic acid that encodes a useful, therapeutic gene to exchange a mutated gene. The compound molecule is packaged along with a "vector” that carries the molecule within cells. The vector incorporates genes into chromosomes. The expressed nucleases then knock out and replace genes within the body. These therapies have had good results, though the deficiency of the beginning material could represent a significant limitation.
- Track 8-1Cell-based Assays
- Track 8-2Cell Therapy Products
- Track 8-3Process of Gene Therapy
- Track 8-4Different Vectors for Gene Therapy
- Track 8-5Process and Pathways Development for MSC based Production
Tissue engineering evolved from the field of biomaterials development and refers to the practice of combining scaffolds, cells, and biologically active molecules into functional tissues. The goal of tissue engineering is to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs. Artificial skin and cartilage are examples of built tissues that are approved by the Food and Drug Administration.
- Track 9-1Regeneration by 3D Printing
- Track 9-2Regeneration with Drugs
- Track 9-3Regeneration with Biomaterial
- Track 9-4Signal needed to regenerate of cell and organ
- Track 9-5Synthetic Scaffold
Cellular engineering applies the principles and methods of engineering to the problems of the cell and molecular biology. As biomedical engineering has shifted from the organ and tissue level to the cellular and sub-cellular level, cellular engineering has emerged as a brand new field. A cornerstone of much of this activity is cell culture technology, i.e., the ability to grow living cells within the artificial environment of a laboratory. Cellular engineering includes the role of engineering in both basic cell biology research and within the creating of products that use living cells, e.g., tissue engineering and bioprocess engineering.
- Track 10-1 Bioprocess Engineering
- Track 10-2Cellular Mechanics and Cell Signaling
- Track 10-3Gene Chips
Teeth are the foremost natural, noninvasive source of stem cells. Dental stem cells, that are straightforward, convenient, and reasonable to gather, hold promise for a variety of very potential therapeutic applications. Dental stem cells provide an awfully promising therapeutic approach to restoring structural defects and this idea is extensively explored by many researchers that are obvious by the speedily growing literature in this field.
- Track 11-1Collection and Preservation of Dental Stem Cells
- Track 11-2Regeneration of Functional Tooth
- Track 11-3Dental Stem Cell Banking
Immunotherapy could be a broad category of cancer therapies that use the body’s immune system to fight cancer cells. These cells are totally different from normal cells, in this, they don’t die normally. Consider these rapidly dividing cells like an out-of-control copy machine that won’t stop making images. These abnormal cells frequently modification, or “mutate,” to evade the immune system. Immunotherapy medicines that are designed to alert the immune system regarding these mutated cells so that it will find and destroy them. Immunotherapies are divided into 3 general categories: 1.Checkpoint Inhibitors are the disrupt signals that enable cancer cells to cover from an immune attack 2.Cytokines are the protein molecules that facilitate regulate and direct the immune system 3.Cancer vaccines that are used to each treat and stop cancer by targeting the immune system.
- Track 12-1Vaccination
- Track 12-2Immune enhancement therapy
- Track 12-3Genetically Engineered T cells
- Track 12-4Suppression Immunotherapies
Gene therapy is designed to introduce genetic material into cells to compensate for abnormal genes and to form a beneficial protein. If a mutated gene causes a necessary protein to be faulty or missing or misfunctional, gene therapy could also be introduced with a normal copy of the gene to restore the function of the protein. Researchers usually do that employing a virus to hold the genetic cargo into cells, as a result of that’s what viruses evolved to do with their own genetic material. In the future, this technique could permit doctors to treat a disorder by inserting a gene into a patient’s cells rather than using medicine or surgery.
- Track 13-1Vectors : Viral and Non-viral
- Track 13-2 Therapeutic Gene Modulation
- Track 13-3Delivery System of Genes
Guided Tissue Regeneration (GTR) are as defined procedures of attempting to regenerate lost periodontal structures through differential tissue responses. It is focused on the development of hard tissue as well as soft tissues of the periodontal attachment. By using GTR, 3-dimensional tissues that literally integrate with a patient's body are been produced.
- Track 14-1Space for bone growth
- Track 14-2 Blood Clot Formation
- Track 14-3Barrier Membrane
- Track 14-4Natural Bioresorable Membrane
This interdisciplinary engineering that has attracted a lot of attention as a brand new therapeutic implies that might overcome the drawbacks involved in the current artificial organs and organ transplantation that have been also aiming at replacing lost or severely damaged tissues or organs. Tissue engineering and regenerative medicine is an exciting research area that aims at regenerative alternatives to harvested tissues for organ transplantation with soft tissues. Though significant progress has been created within the tissue engineering field, several challenges remain and any development in this area would require on-going interactions and collaborations among the scientists from multiple disciplines, and in partnership with the regulatory and therefore the funding agencies. As a result of the medical and market potential, there's important academic and corporate interest during this technology.
- Track 15-13D Printing
- Track 15-2Cell Types Selection
- Track 15-3Scaffold Creation
- Track 15-4Quality Assurance
- Track 15-5Functionality Testing
The pharmaceutical industry faces various challenges within the development of novel compounds. Phase II clinical trial success rates are at a five-year low of 22, and therefore the average range of preclinical programs required to produce one new drug has increased from 12 to 30 between 2007 and 2012 alone. As a result, the average new drug needs over $1.8 billion dollars and 12 years from the time of discovery to commercial launch. To counteract these high attrition rates and increased prices, drug developers need to be able to predict and identify potential efficacy and issues of safety as early as possible throughout the drug discovery process. Doing so can change a lot of attention to be focused on programs with best possibilities of progressing through end-stage clinical trials instead of expensive failures.
Since the invention of patient specific drug discovery or personal medicines. Personalized medicine, also termed as precision medicine, could be a medical procedure that separates patients into completely different groups—with medical decisions, practices, interventions and/or product being tailored to the individual patient based on their predicted response or risk
- Track 16-1Personalized Medicine
- Track 16-2Pharmacogenomics
- Track 16-3Pathways
- Track 16-4Pharmacogenitics & Individualized Therapy
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology that deals with the "process of substitution, engineering or recreating human cells, tissues or organs to restore or establish normal functioning of cell”. Combinations of those approaches will amplify our natural healing process in the places it is required most, or take over the function of a permanently damaged organ. Regenerative medicine is a relatively new field that brings along consultants in biology, chemistry, engineering, engineering, genetics, medicine, robotics, and alternative fields to find out solutions to a number of the foremost difficult medical issues faced by human beings.
The promising field of regenerative medicine is working to restore structure and function of damaged tissues and organs. It’s also working to create solutions for organs that become permanently broken. The goal of this approach is to find out a way to cure previously untreatable injuries and diseases.
- Track 17-1Anti aging medicines
- Track 17-2Medical Devices and Artificial Organs
- Track 17-3Clinical Translation
Stem cells have the exceptional potential to develop into many different cell types within the body throughout early life and growth. In addition to that, in several tissues they function a sort of internal repair system, dividing essentially without limit to refill different cells as long as the person or animal remains alive. Once a stem cell divides itself, and then each new cell has the potential either to stay as a stem cell or become another type of cell with an improved specialized function, such as a muscle cell, a red blood cell, or a nerve cell. Stem cells come from 2 main sources: embryonic stem cells, Embryos formed during the blastocyst phase of embryological development and adult stem cells. Both types are typically characterized by their efficiency, or potential to completely differentiate into different cell type.
- Track 18-1Stem Cell Therapy
- Track 18-2 Biobanks for Pluripotent Stem Cells
- Track 18-3Stem Cell Apoptosis and Signal Transduction
- Track 18-4Stem Cell Nano-Technology
- Track 18-5Stem cell treatment
- Track 18-6Fetal stem cell Banking
- Track 18-7Tissue stem cells
- Track 18-8Application of stem cell
Tissue culture is a technique of scientific research during which fragments of tissue from an animal or plant are collected and transferred to artificial surroundings in which they can survive and function. The cultured tissue may consist of a single cell, a population of cells, or a part of an organ. Cells in culture could multiply, change size, form, or function, exhibit specialized activity or interact with different cells. Cryopreservation is a process where organelles, cells, tissues, extracellular matrix, organs or any other biological constructs vulnerable to damage caused by unregulated chemical kinetics are preserved by cooling to very low temperatures.
- Track 19-1Primary Cell Cultures
- Track 19-2Continuous Cell Lines
- Track 19-3Preservation and Storage
- Track 19-4Proembryonic Stem Cell Research
- Track 19-5Cryopreservation
Regeneration is that the progression of renewal, regeneration, and growth that makes it cells, organ regeneration to natural changes or events that cause damage or disturbance. This study is carried out as craniofacial tissue engineering, in-situ tissue regeneration, adipose-derived stem cells for tissue science which is also a breakthrough in cell culture technology. The study isn't stopped with the regeneration of tissue wherever it is further carried out in relation with cell signaling, morphogenetic proteins. Most of the neurological disorders occurred accidentally having a scope of recovery by replacement or repair of intervertebral discs repair, spinal fusion and plenty of more advancement.
- Track 20-1Tissue Remodelling
- Track 20-2Effects of guided Tissue Regeneration
- Track 20-3Advancements in biomedical and tissue engineering techniques
- Track 20-4Translational Diagnostics
- Track 20-5Tissue Regeneration using Nanotechnology
- Track 20-6Epigenetic
Dental problems caused by dental caries, periodontal disease and tooth injury compromise the oral and general health issues. Current advances in the development of regenerative therapy have been influenced by our understanding of embryonic development, stem cell biology, and tissue engineering technology. Tooth regeneration is a field of regenerative medicine procedure within the field of tissue engineering and stem cell biology to exchange damaged or lost teeth by re-growing them from autologous stem cells.
Dental stem cells and cell-activating cytokines are thought to be candidate approach for tooth tissue regeneration as results of they have the potential to differentiate into tooth tissues in vitro and in vivo. Whole tooth replacement therapy is taken into consideration to be an attractive idea for next generation regenerative therapy as a type of bioengineered organ replacement.
- Track 21-1Dental Lamina
- Track 21-2Regeneration of Fill Cavities
- Track 21-3Dental stem cells
Translational medicine(TM) is a speedily growing discipline in biomedical research and aims to expedite the invention of latest diagnostic tools and treatments by using a multi-disciplinary, very collaborative; "bench-to-bedside" approach. Within public health, translational medicine is concentrated on ensuring that established strategies for disease treatment and prevention are actually implemented within the community. Therefore Tm is outlined as an interdisciplinary branch of the biomedical field supported by three main pillars that are bench side, bedside, and community.
- Track 22-1Genetic Modification of cells and tissues
- Track 22-2Clinical Biostatistics
- Track 22-3Vaccination and Immunotherapy
- Track 22-4Clinical and Translational Medicine
Although most living organisms are composed of enormous amounts of water, it's not inevitable that freezing these organisms ends up in ice-formation. Among amphibians and insects that may tolerate freezing, there's wide variation in the quantity of freezing they'll tolerate. Species of frogs will spend days or weeks "with as much as 65 percent of their total body water as ice". Some amphibians attain their protection due to the glycerol produced by their livers. Glycerol is "antifreeze", it reduces ice formation and lowers freezing point. The sugar glucose is also cryoprotectants. Arctic frogs have a special type of insulin that accelerates glucose release and absorption into cells as temperatures approach freezing point. Cryoprotectants can be used to make water harden like glass with no crystal formation this is a process known as Vitrification. Freezing damage to cells is due to the formation of ice-crystals. Entire organs could also be solidified and kept at temperatures as low as -140°c. Scientists are working on ways in which reduce the toxicity of the cryoprotectants used to make water vitrify to allow banking of organs for transplantation. We tend to are optimistic that the toxicity that also can occur with vitrification of human organs that are going to be reversible with future molecular repair technology.
- Track 23-1Cryopreservation
- Track 23-2 Simplified Manufacturing process
- Track 23-3Short term and Long term Tissue Preservation
- Track 23-4Biological effects of freezing and supercooling
- Track 23-5Vitrification versus slow freezing